FDA Approves Opdivo, Yervoy Combination For Kidney Cancer | Latest News RSS feed

FDA Approves Opdivo, Yervoy Combination For Kidney Cancer - Latest News


NICE turns down Opdivo/Yervoy combo for kidney cancer

The National Institute for Health and Care Excellence has published draft guidelines rejecting NHS funds for Opdivo/Yervoy for ... to the NHS. The combination was approved in the US earlier this year ... read more

FDA OKs Bristol-Myers' Opdivo + Yervoy for first-line kidney cancer

The FDA approves Bristol-Myers Squibb's (BMY-8.4%) combination of Opdivo (nivolumab) and Yervoy (ipilimumab) for the first-line treatment of patients with intermediate- and poor-risk advanced renal ce... read more

BMS claims rapid FDA nod for Opdivo plus Yervoy in kidney cancer

The combination of Opdivo and Yervoy lies at the heart of much of Bristol-Myers Squibb’s ambition in immuno-oncology, and an FDA approval for the pairing in kidney cancer is a boost for the company. T... read more

Looking for another news?


BMS' Opdivo, Yervoy combo approved for first-line kidney cancer

Bristol-Myers Squibb's Opdivo, or nivolumab, in combination with Yervoy, or ipilimumab, was approved by the FDA as a treatment for patients with intermediate- and poor-risk advanced renal cell carcino... read more


Immunotherapy combo not approved for advanced kidney cancer patients on the NHS

People with a certain type of advanced kidney cancer will not be able to have a combination of two immunotherapy ... called ipilimumab (Yervoy) and nivolumab (Opdivo), to people with advanced and aggr... read more

FDA approves Bristol-Myers drug for new use in kidney cancer

The FDA first approved Opdivo for melanoma last December. Opdivo is part of a new class of drugs that work by blocking a protein that prevents the body's immune system from attacking cancer cells. Sim... read more

BMS’ Opdivo/Yervoy combo cleared for kidney cancer

US regulators have approved a combination of Bristol-Myers Squibb ... patients across PD-L1 expression levels.” Lung cancer success Meanwhile, BMS also unveiled new data showing that the Opdivo/Yervoy ... read more

Dr. Amin on CheckMate-214 Trial in RCC

Asim Amin, MD, PhD, director of immunotherapy, Levine Cancer ... (Opdivo) and ipilimumab (Yervoy). The checkpoint inhibitor combination had previously demonstrated significant clinical activity in pat... read more

5 Biotech Stocks Set to Bounce Back in '19 After a Rough Ride

However, Bristol-Myers cancer drug combination Opdivo+Yervoy was approved for first-line kidney cancer in April ... Also, management will meet with the FDA in first quarter of 2019 to discuss ... read more

Roche Gains FDA Approval In Front-Line NSCLC, But The Biggest Battle Still Lies Ahead

Roche received FDA approval for a Tecentriq ... rounded data in the front-line lung cancer space. It's having issues with its combination of Opdivo and Yervoy in treating front-line lung cancer. read more

U.S. FDA approves Bristol-Myers' Opdivo for bladder cancer

kidney cancer, and Hodgkin lymphoma. Investors were disappointed last month when Bristol-Myers said it would not seek accelerated FDA approval for a combination of Opdivo and another immunotherapy, Ye... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us